RNTX
Rein Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$0.89
+5.39%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-487.9%
Return on equity
-75.4%
Return on assets
-203.5%
Return on invested capital
0.00x
Asset turnover
-$18.8M
Cash from operations
$0.47
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026